# OnCo record 23andme-hoxb13-report (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/23andme-hoxb13-report/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "23andme-hoxb13-report" ;
  schema:name "23andMe Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)"@en ;
  schema:description "A saliva test sold directly to the public that looks for one change in the HOXB13 gene, which raises a man's risk of prostate cancer. A negative result does not rule out other inherited prostate cancer risk."@en ;
  schema:url <https://onco.cc/drugs/23andme-hoxb13-report/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K211499> ;
  onco:status "approved" ;
  onco:tag "test", "hereditary" ;
  onco:modality "Direct-to-consumer saliva genetic test (genotyping) for the HOXB13 G84E variant" ;
  schema:alternateName "23andMe PGS Genetic Health Risk Report for Hereditary Prostate Cancer (HOXB13-Related)" ;
  onco:approval "US 2022: Over-the-counter report of the HOXB13 G84E variant (510(k) K211499)" ;
  onco:technologies <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/hoxb13/> ;
  onco:companies <https://onco.cc/companies/23andme/> ;
  onco:terms <https://onco.cc/terms/hereditary-cancer-syndromes/> .